Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the…

A recent randomized trial showed that artemisinin–naphthoquine (AN) was non-inferior to artemether–lumefantrine (AL) for falciparum malaria and superior for vivax malaria in young Papua New Guinean children.

Link to original: 

Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the…